Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project
This article, published in The Journal of Health, Population, and Nutrition, summarizes the general steps required for meningococcal vaccine development, reviews the use of immunogenicity criteria as a licensing strategy for new meningococcal vaccines, and discusses plans for evaluating the impact of a meningococcal A conjugate vaccine in Africa. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Soriano-GabarrĂ³ M, Rosenstein N, LaForce FM
Published: 2004
Visit web page (English)
(Located at www.ncbi.nlm.nih.gov)
Citation: Soriano-Gabarró M, Rosenstein N, LaForce FM. Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project. Journal of Health, Population, and Nutrition. 2004;22(3):275-285.
Resource types: Peer-reviewed journal
Diseases: Meningococcus
Topics: Disease/vaccine specific information
Regions: Africa

